RESPeRATE is a breathing device approved by the FDA to help lower blood pressure. It’s built on the theory that taking slow and deep breaths can help balance the autonomic functions in the central ...
The computerized musical device called RESPeRATE helps people breathe slowly and lowers their blood pressure, research shows. The RESPeRATE device sells for about $300. Its manufacturer, InterCure Ltd ...
Is there something vaguely disconcerting about a medical device that comes with a "Quick Start" guide? Don't be scared: InterCure's RESPeRATE is fairly harmless as medi-gadgets go, a specialized audio ...
NEW YORK--(BUSINESS WIRE)--InterCure Ltd., a medical device company publicly traded on the Tel-Aviv Stock Exchange (TASE: INCR), today announced that RESPeRATE ®, the world’s first FDA-cleared, ...
New York, NY—March 9, 2009—InterCure Ltd., a medical device company publicly traded on the Tel-Aviv Stock Exchange (TASE: INCR), today announced a new study published in the peer-reviewed Journal of ...
RESPeRATE is a noninvasive medical device for the treatment of hypertension (high blood pressure). It works by tracking a person’s breathing and guiding them to breathe more slowly. Original Medicare ...
InterCure Ltd., today announced that RESPeRATE—the only medical device cleared by the FDA and CE-approved for the adjunctive treatment of hypertension. InterCure Ltd., a medical device company ...
The product: RESPeRATE looks like the subject line of a junk e-mail, but it’s actually the name of a medical device designed to lower blood pressure by slowing down breathing. Sold over the Internet ...
New York, N.Y.—April 22, 2009—InterCure Ltd., a medical device company publicly traded on the Tel-Aviv Stock Exchange (TASE: INCR), today announced that RESPeRATE—the only medical device cleared by ...
It might be hard to believe that anything other than a pill could alleviate hypertension for longer than a couple days, yet evidently, there is a way with the development of RESPeRATE, an electronic ...
NEW YORK--(BUSINESS WIRE)--InterCure Ltd., a medical device company publicly traded on the Tel-Aviv Stock Exchange (TASE: INCR), today announced that its RESPeRATE ® hypertension treatment device, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results